Recruiting

Diet Impact

Sponsor:

Clinical Evaluation Research Unit at Kingston General Hospital

Code:

NCT04013776

Conditions

Cardiovascular Diseases

Aging

Nutrient; Excess

Eligibility Criteria

Sex: All

Age: 20 - 40

Healthy Volunteers: Accepted

Interventions

Phosphate supplemented diet

Study Details

Brief summary:

Phosphate is present in many of the foods that the investigators eat and is required by many cellular processes. The kidneys are the only organ that excrete the extra phosphate from the diet that the body does not require. Phosphate is linked to vascular calcification and cardiovascular disease. Measures of serum phosphate do not reflect the burden of phosphate and are not sensitive to early changes in the way the kidneys eliminate phosphate. This study will determine whether the kidneys handle an oral phosphate load differently after 5 days of a low phosphate diet compared to 5 days of a high phosphate diet.

Conditions

Cardiovascular Diseases

Aging

Nutrient; Excess

Study ID

NCT04013776

Start date

May 1, 2017

Status verified date

Jul, 2019

Completion date

Sep 30, 2019

Anticipated

Primary completion date

Sep 30, 2019

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 20 - 40

Healthy Volunteers: Accepted

Inclusion Criteria:

  • healthy
  • between ages of 20 and 40

Exclusion Criteria:

  • known heart disease
  • known diabetes
  • pregnant
  • breast-feeding

Study Design

Enrollment

20 participants

Anticipated

Allocation

Randomized

Intervention Model

Crossover

Primary purpose

Other

Interventions and Outcome Measures

Arms

active comparator: Phosphate supplemented diet

All participants will undergo phosphate testing after following a phosphate supplemented diet for 5 days

no intervention: Low phosphate diet

All participants will undergo phosphate testing after following a low phosphate diet for 5 days

Interventions

Phosphate supplemented diet

Participants will be asked to follow a 5 day menu of 750 mg of phosphorus daily along with a daily sodium phosphorus supplement of 500 mg

Primary outcome measure

  • Urinary phosphate excretion [ Time Frame: 3 hours ]

Central Contacts and Locations

Central contacts

Locations

Queen's University

Recruiting

Kingston, Ontario, Canada, K7L3V6

Contacts

More Information

Sponsor

Clinical Evaluation Research Unit at Kingston General Hospital

Last update posted

Jul 12, 2019

Last verified

Jul, 2019

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Clinical Evaluation Research Unit at Kingston General Hospital on 2019-07-12.